Share this Job

Assistant Scientist 1

Req ID:  45477
Location: 

Tranent, ELN, GB, EH33 2NE

For 70 years, Charles River employees have worked together to assist in the discovery, development and safe manufacture of new drug therapies. When you join our family, you will have a significant impact on the health and well-being of people across the globe. Whether your background is in life sciences, finance, IT, sales or another area, your skills will play an important role in the work we perform. In return, we’ll help you build a career that you can feel passionate about.

Job Summary

The successful candidate will work within the Discovery Pharmacokinetics (PK) group, which works with a broad ranges of clients at different stages of the drug discovery process who are aiming to identify potential drug development candidates. As an Assistant Scientist you will work with the Study Directors in the group to plan and execute non-GLP PK studies in various rodent and non-rodent species. You will work closely with colleagues on-site in Edinburgh and with the Project Teams across Charles River and within the client companies to provide a high quality and efficient in vivo PK service. You will be closely involved in the day to day running of studies and will be required to provide assistance with all aspects of study conduct and reporting, including the following:

  • Provide assistance with study set-up, sample collection, data and report compilation and inter-area collaboration
  • Conduct laboratory work in accordance with Standard Operating Procedures
  • Undertake routine tasks of laboratory and equipment maintenance as may be delegated
  • Ensuring that a safe working environment is maintained by observing all safety procedures and working methods and by making proper use of protective clothing and equipment

 

The following are minimum requirements related to the Assistant Scientist position:

  • A degree in a life science subject, ideally either in Pharmacology, Physiology or Biochemistry
  • A good understanding of the drug discovery/development process
  • Some laboratory experience in the conduct of in vivo metabolism studies would be advantageous however, full training will be provided
  • Ability to prioritise and manage time effectively
  • Highly motivated individual, able to flourish in a fast moving environment
  • Good problem solving skills and be able to work to tight deadlines and record data accurately
  • Good written and verbal communication skills
  • A strong commitment to producing quality data
  • Basic knowledge of Microsoft Office applications (including Word and Excel) is essential

 

Salary will be dependent on level of qualification and banding for this position is £21,101 - £22,967 Successful candidates will be appointed to the bottom of the pay band if they have no relevant experience.

 

Closing Date: 30 July 2019

About Safety Assessment
Charles River is committed to helping our partners expedite their preclinical drug development with exceptional safety assessment services, state-of-the-art facilities and expert regulatory guidance. From individual specialty toxicology and IND enabling studies to tailored packages and total laboratory support, our deeply experienced team can design and execute programs that anticipate challenges and avoid roadblocks for a smooth, efficient journey to market.  Each year approximately 120 investigational new drug (IND) programs are conducted in our Safety Assessment facilities.

About Charles River
Charles River is an early-stage contract research organization (CRO). We have built upon our foundation of laboratory animal medicine and science to develop a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP, to support clients from target identification through preclinical development. Charles River also provides a suite of products and services to support our clients’ clinical laboratory testing needs and manufacturing activities. Utilizing this broad portfolio of products and services enables our clients to create a more flexible drug development model, which reduces their costs, enhances their productivity and effectiveness to increase speed to market.

With over 11,000 employees within 70 facilities in 18 countries around the globe, we are strategically positioned to coordinate worldwide resources and apply multidisciplinary perspectives in resolving our client’s unique challenges.  Our client base includes global pharmaceutical companies, biotechnology companies, government agencies and hospitals and academic institutions around the world. And in 2016, revenue increased by 23.3% to $1.68 billion from $1.36 billion in 2015.

At Charles River, we are passionate about our role in improving the quality of people’s lives. Our mission, our excellent science and our strong sense of purpose guide us in all that we do, and we approach each day with the knowledge that our work helps to improve the health and well-being of many across the globe. We have proudly supported the development of ~70% of the drugs approved by the FDA in 2016.

For more information, please visit www.criver.com.